Recent blog posts
Abarceo Pharma Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
Latest Hotspot
5 min read
Abarceo Pharma Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
23 July 2026
A 2026 partnering scan of Abarceo Pharma, covering pipeline ownership and stage, evidence requirements, IP risk, deal precedent, financial signals and a prioritized outreach shortlist.
Read →
Cardiff Oncology, Inc Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
Latest Hotspot
5 min read
Cardiff Oncology, Inc Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
23 July 2026
A 2026 partnering scan of Cardiff Oncology, Inc, covering pipeline ownership and stage, evidence requirements, IP risk, deal precedent, financial signals and a prioritized outreach shortlist.
Read →
Forward Pharma A/S Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
Latest Hotspot
5 min read
Forward Pharma A/S Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
23 July 2026
A 2026 partnering scan of Forward Pharma A/S, covering pipeline ownership and stage, evidence requirements, IP risk, deal precedent, financial signals and a prioritized outreach shortlist.
Read →
Actinobac Biomed Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
Latest Hotspot
5 min read
Actinobac Biomed Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
23 July 2026
A 2026 partnering scan of Actinobac Biomed, covering pipeline ownership and stage, evidence requirements, IP risk, deal precedent, financial signals and a prioritized outreach shortlist.
Read →
Dyadic International, Inc Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
Latest Hotspot
5 min read
Dyadic International, Inc Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
23 July 2026
A 2026 partnering scan of Dyadic International, Inc, covering pipeline ownership and stage, evidence requirements, IP risk, deal precedent, financial signals and a prioritized outreach shortlist.
Read →
Curasight A/S Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
Latest Hotspot
5 min read
Curasight A/S Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
23 July 2026
A 2026 partnering scan of Curasight A/S, covering pipeline ownership and stage, evidence requirements, IP risk, deal precedent, financial signals and a prioritized outreach shortlist.
Read →
Ainos, Inc Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
Latest Hotspot
5 min read
Ainos, Inc Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
23 July 2026
A 2026 partnering scan of Ainos, Inc, covering pipeline ownership and stage, evidence requirements, IP risk, deal precedent, financial signals and a prioritized outreach shortlist.
Read →
Anika Therapeutics, Inc Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
Latest Hotspot
5 min read
Anika Therapeutics, Inc Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
23 July 2026
A 2026 partnering scan of Anika Therapeutics, Inc, covering pipeline ownership and stage, evidence requirements, IP risk, deal precedent, financial signals and a prioritized outreach shortlist.
Read →
CG Oncology Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
Latest Hotspot
5 min read
CG Oncology Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
23 July 2026
A 2026 partnering scan of CG Oncology, covering pipeline ownership and stage, evidence requirements, IP risk, deal precedent, financial signals and a prioritized outreach shortlist.
Read →
Endogena Therapeutics Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
Latest Hotspot
5 min read
Endogena Therapeutics Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
23 July 2026
A 2026 partnering scan of Endogena Therapeutics, covering pipeline ownership and stage, evidence requirements, IP risk, deal precedent, financial signals and a prioritized outreach shortlist.
Read →
Hugel, Inc Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
Latest Hotspot
5 min read
Hugel, Inc Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
23 July 2026
A 2026 partnering scan of Hugel, Inc, covering pipeline ownership and stage, evidence requirements, IP risk, deal precedent, financial signals and a prioritized outreach shortlist.
Read →
Exopharm Limited Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
Latest Hotspot
5 min read
Exopharm Limited Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
23 July 2026
A 2026 partnering scan of Exopharm Limited, covering pipeline ownership and stage, evidence requirements, IP risk, deal precedent, financial signals and a prioritized outreach shortlist.
Read →